NAICS 325413

In-Vitro Diagnostic Substance Manufacturing

Sector 32 — Manufacturing

Also classified as:
UN ISIC Rev. 4 2029 ≈ UN ISIC Rev. 4 2100 ≈ EU NACE Rev. 2.1 21.10 ≈ EU NACE Rev. 2.1 21.20 ≈ NA NAICS 2022 325413 AU/NZ ANZSIC 2006 1334 ≈ AU/NZ ANZSIC 2006 1813 ≈ AU/NZ ANZSIC 2006 1841
ISIC ↔ NACE crosswalk → ISIC ↔ NAICS crosswalk → ISIC ↔ ANZSIC crosswalk →

GTIAS Industry Analysis Available

This NAICS code maps to a fully analysed industry with an 81-attribute GTIAS scorecard, risk scenarios, and 42+ strategic frameworks.

View Industry Analysis →

About This Industry

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

Cross-References.
Establishments primarily engaged in manufacturing in-vivo diagnostic substances are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.

ISIC Rev. 4 Equivalents

NAICS 325413 maps to the following ISIC Rev. 4 classes:

View the full NAICS ↔ ISIC alignment table →